Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for treating inflammatory diseases and certain cancers. Its structure supports binding to specific enzyme targets, enhancing drug efficacy. Also employed in agrochemicals to improve the stability and bioavailability of active ingredients in crop protection products. The difluoromethoxy group contributes to metabolic stability and membrane permeability, making it valuable in optimizing pharmacokinetic properties in drug design.